FRI-467 - Incidence and risk of dyslipidemia and hyperglycemia in a phase 3 study of obeticholic acid for the treatment of non-alcoholic steatohepatitis
- Resource Type
- Abstract
- Source
- In
Journal of Hepatology June 2023 78 Supplement 1:S809-S810 - Subject
- Language
- ISSN
- 0168-8278